文献速递胸部CTMR

α-1抗胰蛋白酶缺乏症中肺3He磁共振成像区域气腔扩大的生物标志物

Pulmonary 3He Magnetic Resonance Imaging Biomarkers of Regional Airspace Enlargement in Alpha-1 Antitrypsin Deficiency.
PubMed 文献 · Acad Radiol · 2017-06-20

该概念验证研究纳入α-1抗胰蛋白酶缺乏症(AATD)患者8例、慢性阻塞性肺疾病(COPD)戒烟者8例和从不吸烟老年对照5例,比较胸部CT与超极化3He MRI测量的肺气肿指标。结果显示AATD患者的MRI衍生ADC、平均线性截距和表面积体积比与COPD戒烟者显著不同,而CT RA950和一氧化碳弥散量无显著差异,提示MRI测量对AATD肺气肿更敏感。

要点

  • AATD患者MRI衍生ADC(P=.03)、平均线性截距(P<.0001)和表面积体积比(P<.0001)与COPD戒烟者显著不同。
  • CT低衰减区≤-950 HU(RA950)在AATD与COPD戒烟者间无显著差异(P>.05)。
  • 一氧化碳弥散量、残气量和肺总量在AATD与COPD戒烟者间无显著差异(P>.05)。

核心结论

  • 在AATD患者中观察到MRI肺气肿生物标志物较COPD戒烟者显著更差,而CT RA950和一氧化碳弥散量无显著差异,凸显MRI测量对AATD肺气肿的敏感性。

研究设计与样本

  • 概念验证研究,纳入AATD患者8例(57±7岁)、COPD戒烟者8例(77±6岁)和从不吸烟老年对照5例(64±2岁),在单次2小时访视中完成胸部CT、超极化3He MRI、肺功能、圣乔治呼吸问卷和6分钟步行试验。

关键影像表现/征象

  • AATD患者与COPD戒烟者相比,MRI衍生ADC显著不同(P=.03)。
  • AATD患者与COPD戒烟者相比,MRI衍生平均线性截距显著不同(P<.0001)。
  • AATD患者与COPD戒烟者相比,MRI衍生表面积体积比显著不同(P<.0001)。
  • AATD患者与COPD戒烟者相比,CT低衰减区≤-950 HU(RA950)无显著差异(P>.05)。
  • AATD患者与COPD戒烟者相比,一氧化碳弥散量、残气量和肺总量无显著差异(P>.05)。

诊断标准与关键数值

  • MRI衍生ADC在AATD患者与COPD戒烟者间差异有统计学意义(P=.03)。
  • MRI衍生平均线性截距在AATD患者与COPD戒烟者间差异有统计学意义(P<.0001)。
  • MRI衍生表面积体积比在AATD患者与COPD戒烟者间差异有统计学意义(P<.0001)。
  • CT低衰减区≤-950 HU(RA950)在AATD患者与COPD戒烟者间差异无统计学意义(P>.05)。
  • 一氧化碳弥散量、残气量和肺总量在AATD患者与COPD戒烟者间差异无统计学意义(P>.05)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Thoracic x-ray computed tomography (CT) and hyperpolarized 3He magnetic resonance imaging (MRI) provide quantitative measurements of airspace enlargement in patients with emphysema. For patients with panlobular emphysema due to alpha-1 antitrypsin deficiency (AATD), sensitive biomarkers of disease progression and response to therapy have been difficult to develop and exploit, especially those biomarkers that correlate with outcomes like quality of life. Here, our objective was to generate and compare CT and diffusion-weighted inhaled-gas MRI measurements of emphysema including apparent diffusion coefficient (ADC) and MRI-derived mean linear intercept (Lm) in patients with AATD, chronic obstructive pulmonary disease (COPD) ex-smokers, and elderly never-smokers.

MATERIALS AND METHODS: We enrolled patients with AATD (n = 8; 57 ± 7 years), ex-smokers with COPD (n = 8; 77 ± 6 years), and a control group of never-smokers (n = 5; 64 ± 2 years) who underwent thoracic CT, MRI, spirometry, plethysmography, the St. George's Respiratory Questionnaire, and the 6-minute walk test during a single 2-hour visit. MRI-derived ADC, Lm, surface-to-volume ratio, and ventilation defect percent were generated for the apical, basal, and whole lung as was CT lung area ≤-950 Hounsfield units (RA950), low attenuating clusters, and airway count.

RESULTS: In patients with AATD, there was a significantly different MRI-derived ADC (P = .03), Lm (P < .0001), and surface-to-volume ratio (P < .0001), but not diffusing capacity of carbon monoxide, residual volume or total lung capacity, or CT RA950 (P > .05) compared to COPD ex-smokers with a significantly different St. George's Respiratory Questionnaire.

CONCLUSIONS: In this proof-of-concept demonstration, we evaluated CT and MRI lung emphysema measurements and observed significantly worse MRI biomarkers of emphysema in patients with AATD compared to patients with COPD, although CT RA950 and diffusing capacity of carbon monoxide were not significantly different, underscoring the sensitivity of MRI measurements of AATD emphysema.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Lessard E, Young HM, Bhalla A, et al. Pulmonary 3He Magnetic Resonance Imaging Biomarkers of Regional Airspace Enlargement in Alpha-1 Antitrypsin Deficiency. Acad Radiol. 2017. PMID: 28645458. doi:10.1016/j.acra.2017.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。